Fundz

Courage Therapeutics completes a seed financing round led by Arsenal Bridge Ventures to advance obesity and disease treatments.

PRIVATENov 03, 2025

Round Type

Seed

NewtonBiotechnology

Investors

Arsenal Bridge Ventures

Description

Courage Therapeutics has successfully completed a Seed financing round, bringing its total funding to over $11 million. Led by Arsenal Bridge Ventures, the funding aims to enhance the company's development of innovative treatments for genetic and dietary obesity. CEO Giovanni Ferrara emphasizes the urgent need for effective medications in this area. The company plans to utilize the funds to advance research and expand its team to expedite clinical candidate development.

Quick answer

Courage Therapeutics raised an undisclosed amount in a Seed round, dated November 3, 2025. Investors: Arsenal Bridge Ventures. Courage Therapeutics is based in Newton, Massachusetts, United States.

How much did Courage Therapeutics raise?
Courage Therapeutics raised an undisclosed amount in a Seed round on November 3, 2025.
Who invested in Courage Therapeutics?
Arsenal Bridge Ventures is named as investors in this round.
What does Courage Therapeutics do?
Courage Therapeutics is a pre-clinical stage biopharmaceutical company focused on providing patients with new modalities for treating obesity and diseases of wasting.
Where is Courage Therapeutics based and how big is it?
Courage Therapeutics is based in Newton, Massachusetts, United States. Fundz records about 4 employees.
Who are the decision-makers at Courage Therapeutics?
Fundz holds 1 contact at Courage Therapeutics. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Courage Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • Addition Therapeutics raised $100M (Funding Round) on December 18, 2025.
  • GlycanAge raised $8.7M (Funding Round) on December 18, 2025.
  • FoRx Therapeutics raised $50M (Series A) on December 18, 2025.
  • Novyte Materials raised $459K (Pre-Seed) on December 18, 2025.
  • Nawah Scientific raised $23M (Series A) on December 18, 2025.
  • LeonaBio, Inc. raised $90M (Funding Round) on December 18, 2025.

Who to call at Courage Therapeutics, and when

A new round usually means Courage Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Courage Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Courage Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Courage Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Courage Therapeutics

Location

Newton, Massachusetts, United States

About

Courage Therapeutics is a pre-clinical stage biopharmaceutical company focused on providing patients with new modalities for treating obesity and diseases of wasting. Helmed by CEO Giovanni Ferrara, the company brings together an experienced team of scientists and industry experts focusing on developing scientific discoveries regarding the brain’s response to energy signals from the body. Founder Dr. Roger Cone, the Mary Sue Coleman Director of the Life Sciences Institute and the Vice Provost for the Biosciences Initiative at the University of Michigan, spearheaded the company’s licensing agreement with the University to develop treatments based on a portfolio of intellectual property jointly invented with Courage. The Courage medicinal chemistry team has pending patents on multiple compounds with highly selective and potent MC3R and MC4R activity.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Courage Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Courage Therapeutics's next move

See what Strategic adds

Courage Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.